Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: A randomized, placebo-controlled, double-blind, Phase I clinical trial
Highlights ► HFMD outbreaks cause high mortality in mainland China since 2008. ► Enterovirus 71 (EV71) was associated with high-mortality HFMD outbreaks. ► EV71 vaccine will be the most effective measure to reduce morbidity and mortality. ► The Phase I clinical study evaluated safety and immunogenic...
Gespeichert in:
Veröffentlicht in: | Vaccine 2012-05, Vol.30 (22), p.3295-3303 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights ► HFMD outbreaks cause high mortality in mainland China since 2008. ► Enterovirus 71 (EV71) was associated with high-mortality HFMD outbreaks. ► EV71 vaccine will be the most effective measure to reduce morbidity and mortality. ► The Phase I clinical study evaluated safety and immunogenicity of EV71 vaccine. ► EV71 was well tolerated and highly immunogenic in healthy subjects. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2012.03.010 |